Skip to main content
. Author manuscript; available in PMC: 2009 Sep 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2008 Sep;17(9):2231–2237. doi: 10.1158/1055-9965.EPI-08-0176

Table 1.

Model development and validation; PCCaSO, 2005

Model χ2 df p CFI RMSEA 90% CI AIC Notes
Model Development: First random half of sample (n = 543)
All 14 cons 289.06 77 <.001 0.843 0.071 0.063-0.080 345.06 Dropped MDrec loading <.30
13 cons + 8 pros 542.04 188 <.001 0.837 0.059 0.053-0.065 670.04 Dropped 3 cross-loading cons
10 cons + 8 pros 314.73 134 <.001 0.894 0.050 0.043-0.057 424.73
10 cons, 8 pros + 4 norms 621.72 206 <.001 0.832 0.061 0.056-0.067 759.72 High correlation between
norms and pros .88, p < .001
  10 cons + combined
  pros & norms factor
654.33 208 <.001 0.820 0.063 0.058-0.068 788.33 Not a significant
improvement
  2nd order factor of pros
  & norms correlated
  with 10 cons
640.79 207 <.001 0.825 0.062 0.057-0.068 776.79 Not a significant
improvement
Correlated 4-factor model:
cons, pros, norms, self-
efficacy
1136.11 399 <.001 0.864 0.58 0.054-0.62 1268.11 Examined modification
indices
Added 3 error covariances
to correlated 4-factor model
960.10 396 <.001 0.896 0.051 0.047-0.055 1098.10 Final model. Significant
improvement; χ2Δ = 176.01
(dfΔ = 3)
Final Model Validation
Second random half of
sample (n = 558)
1000.77 396 <.001 0.893 0.052 0.048-0.056 1138.77
Full sample (n = 1,250) 1507.51 396 <.001 0.909 0.047 0.045-0.050 1705.51 See Figure 1
Full sample at 2-week
follow-up (n = 1,036)
1014.93 396 <.001 0.917 .039 0.036-0.042 1212.93

CFI = comparative fit index; RMSEA = root mean square error of approximation; CI = confidence interval; AIC = Akaike information criterion